Tennova Healthcare - Turkey Creek Medical Center Clinical Research Team Gains Ground in Advanced Care for Pulmonary Embolism
9/14/2023
11 Patients Now Successfully Treated in APEX-AV Study
Knoxville, TN (September 14, 2023) – Tennova Healthcare - Tennova Heart, leading heart care provider for Knox County and the surrounding areas, announced today that they have enrolled 11 patients in the clinical research focused on using the innovative treatment using the AlphaVac System (APEX-AV). This device is designed to remove blood clots from the lungs to treat acute intermediate-risk pulmonary embolism (PE), restoring healthy blood flow in the body’s vascular system.
APEX-AV is a single-arm Investigational Device Exemption study enrolling patients with confirmed acute, intermediate-risk PE and is offered at only 30 hospitals in the United States. AngioDynamics initiated the APEX-AV study in partnership with the widely respected Pulmonary Embolism Response Team (PERT) Consortium™. Tennova Healthcare - Turkey Creek Medical Center was chosen as one of those 30 hospitals as a trial-eligible hospital with historical success in multiple cardiovascular-related trials.
“We are honored to be a partner of AngioDynamics and the PERT Consortium in the APEX-AV study,” said Tony Benton, chief executive officer, Tennova Healthcare - East Market. “This milestone is significant in our steps towards increasing access to lifesaving treatments.”
“The APEX-AV study is an important trial for PE,” said Malcolm Foster, III, M.D., Tennova Healthcare - Cardiovascular Disease and Interventional Cardiology and site Principal Investigator. “It will add to the increasing body of evidence that supports catheter-based embolectomy as a safe and efficacious treatment for patients with intermediate-risk PE and will ultimately advance patient care.”
Key Pulmonary Embolism Facts (American Lung Association):
- Pulmonary embolism can be life-threatening, with 10-30% of individuals dying within one month of diagnosis.
- Pulmonary embolism affects around 900,000 people in the U.S. every year.
- In most cases, pulmonary embolism is caused by blood clots in the legs, called deep vein thrombosis, that travel to the lungs.
Visit https://clinicaltrials.gov/ct2/show/NCT05318092 for more information about the APEX-AV Study.
Back